Modeling the implications of changes in vascular calcification in patients on hemodialysis

Kidney International

Volumn 67, Issue 4, 2005, Pages 1532-1538

  Huybrechts, Krista F ^a   Caro, J Jaime ^b   London, Gérard M ^b  

^a CARO RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

Arterial calcification; Cardiovascular risk; End stage renal disease; Hemodialysis

Indexed keywords

C REACTIVE PROTEIN; PHOSPHATE BINDING AGENT; SEVELAMER;

ADULT; AGE; AGED; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ECHOGRAPHY; ELECTRON BEAM TOMOGRAPHY; FEMALE; FRANCE; GENDER; HEMODIALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SURVIVAL;

EID: 16244421054     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00233.x     Document Type: Article

References (24)

1. LONDON GM, GUÉRIN AP, MARCHAIS SJ, et al: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50:600-608, 1996
2. DETRANO RC, WONG ND, DOHERTY TM, et al: Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation 99:2633-2638, 1999
3. RAGGI P, CALLISTER TQ, COOIL B, et al: Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 101:850-855, 2000
4. RAGGI P, COOIL B, CALLISTER TQ: Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J 141:375-382, 2001
5. WONG ND, HSU JC, DETRANO RC, et al: Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 86:495-498, 2000
6. ARAD Y, SPADARO LA, GOODMAN K, et al: Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 36:1253-1260, 2000
7. KONDOS GT, HOFF JA, SEVRUKOV A, et al: Electron-beam tomography coronary artery calcium and cardiac events: A 37-month follow-up of 5,635 initially asymptomatic low- to intermediate-risk adults. Circulation 107:2571-2576, 2003
8. PLETCHER MJ, TICE JA, PIGNONE M, BROWNER WS: Using the coronary artery calcium score to predict coronary heart disease events: A systematic review and meta-analysis. Arch Intern Med 164:1285-1292, 2004
9. LONDON GM, GUÉRIN AP, MARCHAIS SJ, et al: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731-1740, 2003
10. EHRLICH JE, RUMBERGER JA: Detection and clinical management of cardiovascular calcification in ESRD: A review. Dial Transplant 33:306-313, 2004
11. HSU CH: Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 29:641-649, 1997
12. BLOCK GA: Prevalence and clinical consequences of elevated Ca × P product in hemodialysis patients. Clin Nephrol 54:318-324, 2000
13. Physicians'Desk Reference (57th ed.), Montvale NJ, Thomson PDR, 2003
14. CHERTOW GM, BURKE SK, RAGGI P, TREAT TO GOAL WORKING GROUP: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252, 2002
15. CHERTOW GM, RAGGI P, CHASAN-TABER S, et al: Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19:1489-1496, 2004
16. NETER J, KUTNER MH, WASSERMAN W, NACHTSHEIM CJ: Applied Linear Statistical Models (4th ed.), Chicago, McGraw-Hill/Irwin, 1996, pp 1408
17. BLACKER J, GUÉRIN AP, PANNIER B, et al: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938-942, 2001
18. BLACHER J, GUÉRIN AP, PANNIER B, et al: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99:2434-2439, 1999
19. GUÉRIN AP, LONDON GM, MARCHAIS SJ, METIVIER F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014-1021, 2000
20. DUAN N: Smearing estimate: A nonparametric retransformation method. JASA 78:605-610, 1983
21. MANNING WG: The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 17:283-295, 1998
22. NATIONAL KIDNEY FOUNDATION: K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42(Suppl 3):S1-S202, 2003
23. BLOCK GA, HULBERT-SHEARON TE, LEVIN NW, PORT FK: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31:607-617, 1998
24. JANOWITZ WR: Coronary calcium does not accurately predict near-term future coronary events in high-risk adults [letter to the editor]. Circulation 102:E20, 2000